V. V. Venchakova

V. V. Venchakova

Auto-generated profile, based on publicly available information

V. V. Venchakova

Kashkin Research Institute of Medical Mycology, North-Western State Medical University named after I.I. Mechnikov, St. Petersburg, Russia

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2025 in Cell and Tissue Biology
Verified
Journal Article
Closed access
PDF file
ATAnastasia Taraskina
Anastasia Taraskina
ЕFЕ. V. Frolova
Е. V. Frolova
АUА. Е. Uchevatkina
А. Е. Uchevatkina
EOEllina Grigorievna Oganesyan
Ellina Grigorievna Oganesyan
VVV. V. Venchakova
V. V. Venchakova
NVN. V. Vasilyeva
N. V. Vasilyeva
Vulvovaginal candidiasis (VVC) is an infection that affects up to 75% of women of reproductive age worldwide. In approximately 5–10% of women with VVC, the disease becomes chronic and relapses, with four or more exacerbations per year occurring, negatively affecting their reproductive health and quality of life. A balanced immune response and changes in vaginal biota have been shown to play a central role in maintaining mucosal homeostasis. The consequence of the disruption of this balance is the reprogramming of innate immune responses, hyperactivation of the inflammasome, as well as the difficult-to-control reproduction of Candida fungi, which, in turn, leads to the formation of recurrent VVC (RVVC). However, even though microevolutionary processes that trigger the transition of a commensal organism to a pathogen, biome translocation factors, and molecular mechanisms of interactions between its representatives and the local immune response are critical participants in the pathogenesis of the disease and are of primary importance for the development of promising therapeutic approaches to combat RVVC, they are currently insufficiently studied. The review presents information on the characteristics of the innate and adaptive immune response of the vaginal mucosa, the structure of the microbiome associated with the pathogenesis of RVVC, changes in its microecology, key molecules that determine the homeostasis of the biome and the interactions between its representatives (fungi, bacteria). The virulence factors of the fungal pathogen that determine the development of RVVC are described. The paper also discusses new potential strategies for the treatment and/or prevention of VVC based on the molecular mechanisms of interactions between yeast, vaginal bacterial biota, and the local human immune response.

16 September 2026 in Cell and Tissue Biology
Verified
Journal Article
Closed access
PDF file
EFE. V. Frolova
E. V. Frolova
OSO. V. Sekretareva
O. V. Sekretareva
AUA. E. Uchevatkina
A. E. Uchevatkina
VVV. V. Venchakova
V. V. Venchakova
EBEkaterina Burygina
Ekaterina Burygina
NVN. V. Vasilyeva
N. V. Vasilyeva
Objective: Recurrent vulvovaginal candidiasis (RVVC) is currently considered an immunopathological process. Fungal virulence factors and host immune responses, such as NLRP3 inflammasome activation, are thought to play an important role in the development of hyperinflammation. The aim of this study was to investigate the expression patterns of genes encoding key molecules involved in the immunoregulation of the inflammatory response, C. albicans virulence factors, as well as cytokine levels in the vaginal fluid of patients with RVVC. Materials and methods: Gene expression encoding NLRP3, caspase-1 (CASP1), NLRC4, cytokines IL-1β, IL-18, IL-1Ra, and C. albicans virulence factors was determined in the cellular fraction of vaginal washes by quantitative polymerase chain reaction. The levels of IL-1β, IL-18, IL-22, and IL-1Ra were measured by enzyme-linked immunosorbent assay. Statistical analysis was performed using the Python programming language (pandas, numpy, scipy, statsmodels, and matplotlib libraries). Results: Increased NLRP3 inflammasome activity at the local level in RVVC patients was confirmed by enhanced expression of NLRP3, CASP1, and IL1B genes, as well as elevated IL-1β levels compared to the control group. In all RVVC patients, unlike healthy women, expression of the SAP2 gene, associated with the yeast form of C. albicans, as well as SAP5, SAP6, ECE1, and HWP1 genes associated with the yeast-to-hypha transition, was detected. The important role of candidalysin in NLRP3 inflammasome activation was confirmed by a strong correlation between CASP1 and ECE1 expression. A distinctive feature of women with candidal infection was a significant decrease in vaginal IL-18 and IL-1Ra levels, as well as a tendency toward reduced IL-22 concentrations. A negative correlation was found between IL-18 and IL-22 levels and the number of vulvovaginal candidiasis recurrences per year. Conclusion: In RVVC, the IL-18/IL-22/IL-1Ra axis at the local level counteracts C. albicans virulence factors in NLRP3 inflammasome activation and, consequently, prevents the transition of the inflammatory response to a chronic stage and the progression of fungal infection.